chrX-83508979-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_000307.5(POU3F4):c.655C>T(p.Leu219Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00023 in 1,210,905 control chromosomes in the GnomAD database, including 1 homozygotes. There are 150 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.000080 ( 0 hom., 3 hem., cov: 24)
Exomes 𝑓: 0.00025 ( 1 hom. 147 hem. )
Consequence
POU3F4
NM_000307.5 synonymous
NM_000307.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.09
Genes affected
POU3F4 (HGNC:9217): (POU class 3 homeobox 4) This gene encodes a member of the POU-III class of neural transcription factors. This family member plays a role in inner ear development. The protein is thought to be involved in the mediation of epigenetic signals which induce striatal neuron-precursor differentiation. Mutations in this gene are associated with X chromosome-linked nonsyndromic mixed deafness. [provided by RefSeq, Dec 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant X-83508979-C-T is Benign according to our data. Variant chrX-83508979-C-T is described in ClinVar as [Benign]. Clinvar id is 504940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.09 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 3 Mitochondrial gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POU3F4 | NM_000307.5 | c.655C>T | p.Leu219Leu | synonymous_variant | 1/1 | ENST00000644024.2 | NP_000298.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POU3F4 | ENST00000644024.2 | c.655C>T | p.Leu219Leu | synonymous_variant | 1/1 | NM_000307.5 | ENSP00000495996.1 | |||
ENSG00000279437 | ENST00000625081.1 | n.236G>A | non_coding_transcript_exon_variant | 1/1 | 6 |
Frequencies
GnomAD3 genomes AF: 0.0000888 AC: 10AN: 112606Hom.: 0 Cov.: 24 AF XY: 0.0000864 AC XY: 3AN XY: 34738
GnomAD3 genomes
AF:
AC:
10
AN:
112606
Hom.:
Cov.:
24
AF XY:
AC XY:
3
AN XY:
34738
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000469 AC: 86AN: 183446Hom.: 0 AF XY: 0.000707 AC XY: 48AN XY: 67888
GnomAD3 exomes
AF:
AC:
86
AN:
183446
Hom.:
AF XY:
AC XY:
48
AN XY:
67888
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000246 AC: 270AN: 1098245Hom.: 1 Cov.: 31 AF XY: 0.000404 AC XY: 147AN XY: 363599
GnomAD4 exome
AF:
AC:
270
AN:
1098245
Hom.:
Cov.:
31
AF XY:
AC XY:
147
AN XY:
363599
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000799 AC: 9AN: 112660Hom.: 0 Cov.: 24 AF XY: 0.0000862 AC XY: 3AN XY: 34802
GnomAD4 genome
AF:
AC:
9
AN:
112660
Hom.:
Cov.:
24
AF XY:
AC XY:
3
AN XY:
34802
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 12, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 28, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 05, 2016 | p.Leu219Leu in exon 1 of POU3F4: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 0.5% (47/10079) o f South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac .broadinstitute.org; dbSNP rs781092151). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at